Back to Journals » Drug Design, Development and Therapy » Volume 14

The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution

Total article views   HTML views PDF downloads Totals
5,459 Dovepress* 5,207+ 872 6,079
PubMed Central* 252 123 375
Totals 5,459 995 6,454
*Since 25 September 2020

View citations on PubMed Central and Google Scholar